Dirk Fengels
Chief Tech/Sci/R&D Officer bij Sequana Medical AG
Profiel
Dirk Fengels is currently working as the Director of Engineering & Manufacturing at Sequana Medical AG.
Previously, he worked as the Global Vice President of Engineering & Manufacturing at Sequana Medical NV from 2017 to 2020.
Mr. Fengels is a graduate of the Swiss Federal Institute of Technology.
Actieve functies van Dirk Fengels
| Bedrijven | Functie | Begin |
|---|---|---|
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Dirk Fengels
| Bedrijven | Functie | Einde |
|---|---|---|
| SEQUANA MEDICAL N.V. | Chief Tech/Sci/R&D Officer | 01-10-2020 |
Opleiding van Dirk Fengels
| Swiss Federal Institute of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
